paromomycin
Showing 1 - 8 of 8
Primary Visceral Leishmaniasis Trial in Gondar (LXE408, sodium stibogluconate, Paromomycin)
Not yet recruiting
- Primary Visceral Leishmaniasis
- LXE408
- +2 more
-
Gondar, EthiopiaUniversity of Gondar
Jul 14, 2023
Visceral Leishmaniasis Trial in Worldwide (Miltefosine, Paromomycin, Sodium stibogluconate)
Completed
- Visceral Leishmaniasis
- Miltefosine
- +2 more
-
Ābderafī, Amhara, Ethiopia
- +6 more
Jun 10, 2021
Cutaneous Leishmaniasis, American Trial in Jorochito (Miltefosine and Paromomycin, miltefosine, paromomycin)
Completed
- Cutaneous Leishmaniasis, American
- Miltefosine and Paromomycin
- +2 more
-
Jorochito, SC, BoliviaHopital, Dermatologico
Feb 1, 2021
Leishmaniasis, Cutaneous Trial in Bethesda, Multiple Locations (Paromomycin)
No longer available
- Leishmaniasis, Cutaneous
- Paromomycin
-
Bethesda, Maryland
- +1 more
May 13, 2020
PKDL - Post-Kala-Azar Dermal Leishmanioid Trial in Doka (Paromomycin, Ambisome, Miltefosine)
Unknown status
- PKDL - Post-Kala-Azar Dermal Leishmanioid
- Paromomycin
- +2 more
-
Doka, Gedaref, SudanProf. Elhassan Centre for tropical Medicine
Jan 15, 2020
Cutaneous Leishmaniasis Trial in Panama City (WR 279,396, Paromomycin)
Completed
- Cutaneous Leishmaniasis
- WR 279,396
- Paromomycin
-
Panama City, PanamaInstituto Conmemorativo Gorgas de Estudios de la Salud,
Jan 17, 2018
Visceral Leishmaniasis Trial in Varanasi (Paromomycin)
Completed
- Visceral Leishmaniasis
- Paromomycin
-
Varanasi, IndiaKala-azar Medical Research Center, Rambag Road
Sep 11, 2008